February 17, 2022
The Lupus Research Alliance applauds the appointment of Dr. Robert Califf as the Commissioner of the U.S. Food and Drug Administration (FDA). We are confident that Dr. Califf’s world-class expertise in healthcare quality and outcomes as well as clinical research will well enable him to guide the FDA in fulfilling its mission, which includes the advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable…”.
We also thank Dr. Janet Woodcock for her outstanding work as Principal Acting Commissioner and for her long-standing support for the lupus community. As a trained rheumatologist, Dr. Woodcock possesses a special appreciation for the challenges of treating people with lupus and other rheumatic conditions and we are grateful for her willingness to continue to serve in the position of Principal Deputy Commissioner.
The LRA looks forward to working with Drs. Califf and Woodcock in their new roles.
About the Lupus Research Alliance
The Lupus Research Alliance is the largest non-governmental, non-profit funder of lupus research worldwide. The organization aims to transform treatment by funding the most innovative lupus research, fostering diverse scientific talent, and driving discovery toward better diagnostics, improved treatments and ultimately a cure for lupus. Because the Lupus Research Alliance’s Board of Directors fund all administrative and fundraising costs, 100% of all donations goes to support lupus research programs.
